Evidence map›Paper›PMID 26722421›Full record

ArticleInternational journal of clinical and experimental pathology2015

Amplification of chromosome 8q21-qter associated with the acquired paclitaxel resistance of nasopharyngeal carcinoma cells.

Wei Li, Yating You, Xiaowei Zhang, Yexun Song, Hong Xiang, Xiaowei Peng, Jiangbo Qin, Guolin Tan

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact, top 91% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Expression and kinetic characterization of PYCR3.Archives of biochemistry and biophysics · 2023
    Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Wei LiDepartment of Otoalryngology-Head Neck Surgery, Third Xiangya Hospital, Central South University Changsha 410013, Hunan, China.
Yating YouDepartment of Otoalryngology-Head Neck Surgery, Third Xiangya Hospital, Central South University Changsha 410013, Hunan, China.
Xiaowei ZhangDepartment of Otoalryngology-Head Neck Surgery, Third Xiangya Hospital, Central South University Changsha 410013, Hunan, China.
Yexun SongDepartment of Otoalryngology-Head Neck Surgery, Third Xiangya Hospital, Central South University Changsha 410013, Hunan, China.
Hong XiangDepartment of Central laboratory, Third Xiangya Hospital, Central South University Changsha 410013, Hunan, China.
Xiaowei PengDepartment of Head and Neck Surgery, The Affiliated Cancer Hospital of Xiangya Medical School, Central South University Changsha 410013, Hunan, China.
Jiangbo QinDepartment of Head and Neck Surgery, Peace Hospital of Changzhi Medical College Changzhi 046000, Shangxi, China.
Guolin TanDepartment of Otoalryngology-Head Neck Surgery, Third Xiangya Hospital, Central South University Changsha 410013, Hunan, China.
Central South University · CNChangzhi Medical College Peace Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveto observe relationship between chromosome imbalance and taxol resistance in nasopharyngeal carcinoma (NPC).

methodsthree taxol-resistant sub-lines were established through repeated exposure of escalating doses of paclitaxel to NPC cell lines (CNE-1, HNE-2 and 5-8F). The change of copy number of chromosomes was investigated by the genome-wide analyses of comparative genomic hybridization (CGH). Gene profiles of both parental and resistant cell lines were determined by cDNA microarray. Cell viability was assayed by colony formation assay.

resultsThe taxol resistant sub-lines (CNE1/Taxol, HNE2/Taxol and 5-8F/Taxol) developed displayed an average 5~8-fold higher IC50 value than their parental cells. The common losses of chromosome 18, 10q11-qter and gains of chromosome 12, 3q21-qter, 5p13-pter and 20q11-qter were observed by CGH in all of 6 NPC cell lines. A common gain region of chromosome 8q21-qter was identified in taxol resistant sub-lines. 15 genes of 762 transcripts on this chromosome region were consistently up-regulated detected by cDNA microarray in three taxol resistant sub-lines, and functionally clustered into various groups, including genes related to vascular formation vascular formation (ANGPT1), apoptosis (MYC, TOP1MT), cell adhesion and cell cycle (PPP1R16A, SDC2, CA2, ANKRD46), gene regulation (HRSP12, ZNF696, SLC39A4, POP1), metabolism (PYCRL). Inhibition of ANGPT1 expression significantly increased the sensitivity of CNE-1/taxol to paclitaxol.

conclusionThe common gain of chromosome 8q21-qter in taxol resistant sublines predicates that potential candidate genes on this region may contribute to taxol resistant phenotype. ANGPT1 may be associated with taxol resistance of NPC cells.

Indexed as

Gene AmplificationAngiopoietin-1Antineoplastic Agents, PhytogenicBlotting, WesternCarcinomaCell Line, TumorChromosomes, Human, Pair 8Comparative Genomic HybridizationDrug Resistance, NeoplasmGene Expression ProfilingHumansNasopharyngeal CarcinomaNasopharyngeal NeoplasmsOligonucleotide Array Sequence AnalysisPaclitaxelReal-Time Polymerase Chain ReactionAngiopoietin-1ANGPT1 protein, humanAntineoplastic Agents, PhytogenicPaclitaxelAngiopoietinchromosome imbalancedrug resistancenasopharyngeal carcinoma

Identifiers

PMID26722421
PMCPMC4680366
OpenAlexW2223392410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.